FERG.UK

12,320

-0.81%↓

FERG.UK

12,320

-0.81%↓

FERG.UK

12,320

-0.81%↓

FERG.UK

12,320

-0.81%↓

FERG.UK

12,320

-0.81%↓

Search

ConvaTec Group PLC

Uždarymo kaina

SektoriusFinansų sektorius

260 1.01

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

256.4

Max

260.6

Pagrindiniai rodikliai

By Trading Economics

Pajamos

79M

Pardavimai

1.1B

P/E

Sektoriaus vid.

36.657

26.788

Pelnas, tenkantis vienai akcijai

0.07

Dividendų pajamingumas

1.97

Pelno marža

7.059

Darbuotojai

10,489

EBITDA

251M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+22.18% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.97%

4.10%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

232M

5.3B

Ankstesnė atidarymo kaina

258.99

Ankstesnė uždarymo kaina

260

Naujienos nuotaikos

By Acuity

67%

33%

490 / 542 reitingas Finance

ConvaTec Group PLC Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-02-26 13:37; UTC

Rinkos pokalbiai

European Stocks on Track for Record Close as Earnings Lift Mood -- Market Talk

Akcijų palyginimas

Kainos pokytis

ConvaTec Group PLC Prognozė

Kainos tikslas

By TipRanks

22.18% į viršų

12 mėnesių prognozė

Vidutinis 314.25 GBX  22.18%

Aukščiausias 375 GBX

Žemiausias 282 GBX

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines ConvaTec Group PLC kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

8 ratings

8

Pirkti

0

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

490 / 542 reitingas Finansų sektorius

Naujienos nuotaikos

Meškų rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.